Evidence map›Paper›PMID 36932400›Full record

ArticleMalaria journal2023

Trends of insecticide resistance monitoring in mainland Tanzania, 2004-2020.

Patrick Tungu, Bilali Kabula, Theresia Nkya, Pendael Machafuko, Edward Sambu, Bernard Batengana, Wema Sudi, Yahaya A Derua, Victor Mwingira, Denis Masue and 17 more

Open access · goldFull text read
In one paragraph

Article in Malaria journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comparative malaria impact of chlorfenapyr-α-cypermethrin netsCurrent research in parasitology & vector-borne diseases · 2026
    Article
  8. Spatial Heterogeneity ofJournal of parasitology research · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 2 countries.

Patrick TunguNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania. patrickkijatungu@hotmail.com.
Bilali KabulaNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
Theresia NkyaUniversity of Dar es Salaam, Dar es Salaam, Tanzania.
Pendael MachafukoNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
Edward SambuNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
Bernard BatenganaNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
Wema SudiNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
Yahaya A DeruaNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
Victor MwingiraNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
Denis MasueUniversity of Dar es Salaam, Dar es Salaam, Tanzania.
Robert MalimaUniversity of Dar es Salaam, Dar es Salaam, Tanzania.
Chonge KitojoU.S. President's Malaria Initiative, U.S. Agency for International Development, Dar es Salaam, Tanzania.
Naomi SerbantezU.S. President's Malaria Initiative, U.S. Agency for International Development, Dar es Salaam, Tanzania.
Erik J ReavesU.S. President's Malaria Initiative, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Charles MwalimuNational Malaria Control Programme, Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, Tanzania.
Samwel L NhigaNational Malaria Control Programme, Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, Tanzania.
Mohamed AllyNational Malaria Control Programme, Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, Tanzania.
Humphrey R MkaliUSAID-Okoa Maisha Dhibiti Malaria Project, RTI International, Dar es Salaam, Tanzania.
Joseph J JosephUSAID-Okoa Maisha Dhibiti Malaria Project, RTI International, Dar es Salaam, Tanzania.
Adeline ChanU.S. President's Malaria Initiative, U.S. Centers for Disease Control and Prevention, Atlanta, USA.
Jeremiah NgondiRTI International, Washington, DC, USA.
Shabbir LaljiUSAID-Okoa Maisha Dhibiti Malaria Project, RTI International, Dar es Salaam, Tanzania.
Ssanyu NyinondiUSAID-Okoa Maisha Dhibiti Malaria Project, RTI International, Dar es Salaam, Tanzania.
Erin EckertRTI International, Washington, DC, USA.
Richard ReithingerRTI International, Washington, DC, USA.
Stephen MagesaNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
William N KisinzaNational Institute for Medical Research, Amani Medical Research Centre, Muheza, Tanzania.
National Institute for Medical Research · TZPlan International Tanzania · TZMinistry of Health, Community Development, Gender, Elderly and Children · TZRTI International · USUniversity of Dar es Salaam · TZU.S. President's Malaria Initiative · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsecticide resistance is a serious threat to the continued effectiveness of insecticide-based malaria vector control measures, such as long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS). This paper describes trends and dynamics of insecticide resistance and its underlying mechanisms from annual resistance monitoring surveys on Anopheles gambiae sensu lato (s.l.) populations conducted across mainland Tanzania from 2004 to 2020.

methodsThe World Health Organization (WHO) standard protocols were used to assess susceptibility of the wild female An. gambiae s.l. mosquitoes to insecticides, with mosquitoes exposed to diagnostic concentrations of permethrin, deltamethrin, lambdacyhalothrin, bendiocarb, and pirimiphos-methyl. WHO test papers at 5× and 10× the diagnostic concentrations were used to assess the intensity of resistance to pyrethroids; synergist tests using piperonyl butoxide (PBO) were carried out in sites where mosquitoes were found to be resistant to pyrethroids. To estimate insecticide resistance trends from 2004 to 2020, percentage mortalities from each site and time point were aggregated and regression analysis of mortality versus the Julian dates of bioassays was performed.

resultsPercentage of sites with pyrethroid resistance increased from 0% in 2004 to more than 80% in the 2020, suggesting resistance has been spreading geographically. Results indicate a strong negative association (p = 0.0001) between pyrethroids susceptibility status and survey year. The regression model shows that by 2020 over 40% of An. gambiae mosquitoes survived exposure to pyrethroids at their respective diagnostic doses. A decreasing trend of An. gambiae susceptibility to bendiocarb was observed over time, but this was not statistically significant (p = 0.8413). Anopheles gambiae exhibited high level of susceptibility to the pirimiphos-methyl in sampled sites.

conclusionsAnopheles gambiae Tanzania's major malaria vector, is now resistant to pyrethroids across the country with resistance increasing in prevalence and intensity and has been spreading geographically. This calls for urgent action for efficient malaria vector control tools to sustain the gains obtained in malaria control. Strengthening insecticide resistance monitoring is important for its management through evidence generation for effective malaria vector control decision.

Indexed as

AnophelesInsecticidesMalariaPyrethrinsAnimalsFemaleHumansInsecticide ResistanceMosquito ControlMosquito VectorsPhenylcarbamatesTanzaniabendiocarbInsecticidesPhenylcarbamatesPyrethrinsInsecticide resistanceMalaria vectorsResistance trendsTanzania

Identifiers

PMID36932400
PMCPMC10024418
OpenAlexW4327811843

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read80
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.